• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤免疫浸润与胶质母细胞瘤中白细胞的外周循环无关。

Tumour immune infiltration is independent of peripheral circulation of white blood cells in glioblastoma.

作者信息

García-Heredia Anabel, Guerra-Núñez Luna, Iriarte-Gahete Marianela, Espinosa-Lara Pablo, Valor Luis M

机构信息

Research Laboratory, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, 03010, Spain.

Department of Haematology, Immunology and Genetics, Puerta del Mar University Hospital, Cadiz, 11009, Spain.

出版信息

Sci Rep. 2025 Aug 26;15(1):31344. doi: 10.1038/s41598-025-16260-6.

DOI:10.1038/s41598-025-16260-6
PMID:40858716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12381165/
Abstract

Glioblastomas are the most prevalent and malignant primary cancers in the brain. Given the promising prospects of immunotherapeutic approaches, there is increasing interest in obtaining precise knowledge of the immunologic status of the tumour microenvironment for each individual. We explored the feasibility of inferring this tumour immune component in a minimally invasive manner prior to any clinical intervention, taking advantage of the preoperative immune cell counts that can be easily obtained from the clinical records of the patients. The neutrophil-to-lymphocyte ratio (NLR) is the most extensive measure calculated from complete counts of peripheral blood. Despite there was an increase in the NLR in high grade tumours of our cohorts of study, we did not find evidence of any correlation between the NLR and different degrees of tumour immune infiltration in glioblastoma. The same negative result was obtained with the monocyte-to-lymphocyte ratio (MLR). In addition, glioblastomas associated with extreme values of peripheral NLR did not exhibit substantial gene expression differences that could be linked to distinct tumourigenic properties. Overall, these results suggest that peripheral immune cell ratios cannot be used to reliably infer the immune microenvironment within the tumour, underscoring the complexity of using peripheral markers to assess local tumour immunity.

摘要

胶质母细胞瘤是大脑中最常见且恶性程度最高的原发性癌症。鉴于免疫治疗方法前景广阔,人们越来越希望精准了解每个个体肿瘤微环境的免疫状态。我们利用可从患者临床记录中轻松获取的术前免疫细胞计数,探讨了在任何临床干预之前以微创方式推断这种肿瘤免疫成分的可行性。中性粒细胞与淋巴细胞比值(NLR)是根据外周血全血细胞计数计算得出的最常用指标。尽管在我们的研究队列中高级别肿瘤的NLR有所升高,但我们并未发现NLR与胶质母细胞瘤不同程度的肿瘤免疫浸润之间存在任何相关性。单核细胞与淋巴细胞比值(MLR)也得到了相同的阴性结果。此外,外周NLR值极高的胶质母细胞瘤并未表现出与不同致瘤特性相关的显著基因表达差异。总体而言,这些结果表明外周免疫细胞比值不能可靠地推断肿瘤内的免疫微环境,凸显了使用外周标志物评估局部肿瘤免疫的复杂性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d9/12381165/cb4032323a07/41598_2025_16260_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d9/12381165/4d19e1df5acd/41598_2025_16260_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d9/12381165/5f0b22a9823e/41598_2025_16260_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d9/12381165/b70312e373ce/41598_2025_16260_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d9/12381165/cb4032323a07/41598_2025_16260_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d9/12381165/4d19e1df5acd/41598_2025_16260_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d9/12381165/5f0b22a9823e/41598_2025_16260_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d9/12381165/b70312e373ce/41598_2025_16260_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d9/12381165/cb4032323a07/41598_2025_16260_Fig4_HTML.jpg

相似文献

1
Tumour immune infiltration is independent of peripheral circulation of white blood cells in glioblastoma.肿瘤免疫浸润与胶质母细胞瘤中白细胞的外周循环无关。
Sci Rep. 2025 Aug 26;15(1):31344. doi: 10.1038/s41598-025-16260-6.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
4
Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals.在一项超过10万人的普通人群研究中,低度全身炎症与银屑病风险相关。
Br J Dermatol. 2025 Jul 17;193(2):250-258. doi: 10.1093/bjd/ljaf147.
5
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
8
Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.老年新诊断胶质母细胞瘤的治疗:一项网状Meta分析
Cochrane Database Syst Rev. 2020 Mar 23;3(3):CD013261. doi: 10.1002/14651858.CD013261.pub2.
9
The Prognostic Value of Preoperative Inflammatory Markers for Pathological Grading of Glioma Patients.术前炎症标志物对胶质瘤患者病理分级的预后价值。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241273160. doi: 10.1177/15330338241273160.
10
Blood biomarkers for the non-invasive diagnosis of endometriosis.用于子宫内膜异位症无创诊断的血液生物标志物。
Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179.

本文引用的文献

1
Transcriptomics and epigenomics datasets of primary brain cancers in formalin-fixed paraffin embedded format.福尔马林固定石蜡包埋格式的原发性脑癌转录组学和表观基因组学数据集。
Sci Data. 2025 Feb 15;12(1):273. doi: 10.1038/s41597-025-04597-6.
2
Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics.单细胞和空间转录组学揭示 IDH 分层胶质瘤微环境中的独特肿瘤-TAM 相互作用。
Acta Neuropathol Commun. 2024 Aug 16;12(1):133. doi: 10.1186/s40478-024-01837-5.
3
The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients.
中性粒细胞与淋巴细胞比值和 De Ritis 比值在多形性胶质母细胞瘤患者中的预后影响。
Bratisl Lek Listy. 2024;125(8):463-467. doi: 10.4149/BLL_2024_71.
4
Sequential Evaluation of Hematology Markers as a Prognostic Factor in Glioblastoma Patients.胶质母细胞瘤患者血液学标志物作为预后因素的序贯评估
Biomedicines. 2024 May 12;12(5):1067. doi: 10.3390/biomedicines12051067.
5
Neutrophils in glioma microenvironment: from immune function to immunotherapy.胶质细胞瘤微环境中的中性粒细胞:从免疫功能到免疫治疗。
Front Immunol. 2024 May 8;15:1393173. doi: 10.3389/fimmu.2024.1393173. eCollection 2024.
6
Dexamethasone in Patients with Glioblastoma: A Systematic Review and Meta-Analysis.胶质母细胞瘤患者使用地塞米松:一项系统评价与荟萃分析
Cancers (Basel). 2024 Apr 1;16(7):1393. doi: 10.3390/cancers16071393.
7
Systemic and local immunosuppression in glioblastoma and its prognostic significance.脑胶质瘤的全身和局部免疫抑制及其预后意义。
Front Immunol. 2024 Feb 28;15:1326753. doi: 10.3389/fimmu.2024.1326753. eCollection 2024.
8
Neutrophil-to-lymphocyte ratio as a predictive biomarker for early diagnosis of depression: A narrative review.中性粒细胞与淋巴细胞比值作为抑郁症早期诊断的预测生物标志物:一项叙述性综述。
Brain Behav Immun Health. 2024 Feb 5;36:100734. doi: 10.1016/j.bbih.2024.100734. eCollection 2024 Mar.
9
The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson's disease.中性粒细胞与淋巴细胞比值、淋巴细胞与单核细胞比值以及中性粒细胞与高密度脂蛋白比值与帕金森病的严重程度相关。
Front Neurol. 2024 Jan 23;15:1322228. doi: 10.3389/fneur.2024.1322228. eCollection 2024.
10
The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.胶质母细胞瘤患者外周血的免疫格局以及年龄和地塞米松治疗的免疫后果。
Front Immunol. 2024 Jan 18;15:1343484. doi: 10.3389/fimmu.2024.1343484. eCollection 2024.